![Biotech Stocks Facing FDA Decision In December 2021]( "fda-nov29.jpg")
Just when everyone thought that the worst of the Covid-19 pandemic may be behind us, the emergence of Omicron, a new coronavirus variant, is causing global concern. Detected first in South Africa earlier this month, Omicron cases have now been reported in at least 15 countries.
![Biotech Stocks Facing FDA Decision In November 2021]( "fda-oct28.jpg")
Let's take a look at the biotech stocks facing FDA decision in November.
![Biotech Stocks Facing FDA Decision In October 2021]( "fda-sep30.jpg")
The FDA has approved 39 novel drugs so far this year compared to 40 during the same period last year. A total of 53 novel drugs were approved in 2020. Let’s take a look at the biotech stocks facing FDA decision in October.
![Biotech Stocks Facing FDA Decision In September 2021]( "fda-aug26.jpg")
As August draws to a close, let us take a look back at some of the regulatory headlines from that eventful month and look forward to what September has in store.